Get the Stockscreener App
87.85
0.19%
-0.1742
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $87.85, with a volume of 691.77K.
It is down -0.19% in the last 24 hours and up +5.50% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$88.02
Open:
$87.81
24h Volume:
691.77K
Relative Volume:
0.20
Market Cap:
$42.71B
Revenue:
$6.13B
Net Income/Loss:
$272.21M
P/E Ratio:
159.11
EPS:
0.5521
Net Cash Flow:
$1.38B
1W Performance:
+3.72%
1M Performance:
+5.50%
6M Performance:
+17.26%
1Y Performance:
+31.99%
1-Day Range:
$87.78
$88.50
1-Week Range:
$84.72
$88.50
52-Week Range:
$61.76
$88.50
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, AHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
87.85 | 42.79B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
217.66 | 153.12B | 11.75B | 1.46B | 2.19B | -0.6014 |
OHI
Omega Healthcare Investors Inc
|
46.06 | 13.99B | 1.24B | 655.98M | 857.80M | 2.063 |
DOC
Healthpeak Properties Inc
|
16.34 | 11.42B | 2.82B | 100.19M | 1.15B | 0.1011 |
AHR
American Healthcare Reit Inc
|
50.16 | 9.62B | 2.27B | 70.82M | 165.88M | 0.4079 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Goldman | Buy |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
BMO Capital Adjusts Price Target on Ventas to $100 From $93, Maintains Outperform Rating - marketscreener.com
[SCHEDULE 13G/A] Ventas, Inc. Amended Passive Investment Disclosure - Stock Titan
Ventas price target raised to $93 from $85 at UBS - TipRanks
56,455 Shares in Ventas, Inc. $VTR Purchased by Advisors Preferred LLC - MarketBeat
What's in the offing for Ventas stock this earnings season? - MSN
Danske Bank A S Has $18.56 Million Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas boosts full-year earnings guidance as occupancy gains fuel Q1 earnings beat - MSN
Strs Ohio Sells 17,816 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Stake Lessened by Pictet Asset Management Holding SA - MarketBeat
Ventas Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - The National Law Review
Ventas (NYSE:VTR) Price Target Raised to $100.00 at Citigroup - MarketBeat
Free cash flow per share of Ventas, Inc. – FWB:VEN - TradingView
Citi Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $100 - 富途牛牛
Total debt per share of Ventas, Inc. – DUS:VEN - TradingView
Sanctuary Advisors LLC Has $3.73 Million Stake in Ventas, Inc. $VTR - MarketBeat
Ventas expects $3.86 FFO per share in 2026 as it raises investment plan to $3B - MSN
14 Stocks on Jim Cramer’s Radar: Nokia, Cameco, and AI Stocks’ Dip - Insider Monkey
Ventas (NYSE:VTR) Sets New 52-Week HighShould You Buy? - MarketBeat
Jim Cramer on Ventas: “I Think This Is Just a Fantastic Business” - Insider Monkey
Vanguard holds 35.9M Ventas shares—7.55% stake (VTR) - Stock Titan
Ventas stock hits all-time high at 88.37 USD By Investing.com - Investing.com India
Ventas stock hits all-time high at 88.37 USD - Investing.com
Ventas Inc. Earnings Call Signals Strong SHOP Surge - The Globe and Mail
Promising Real Estate Stocks Worth WatchingApril 29th - MarketBeat
[SCHEDULE 13G] Ventas, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Argus Adjusts Price Target on Ventas to $92 From $88, Maintains Buy Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Ventas to $95 From $94, Maintains Outperform Rating - marketscreener.com
Analysts Offer Insights on Real Estate Companies: Public Storage (PSA) and Ventas (VTR) - The Globe and Mail
Ventas Inc Strengthens Healthcare Real Estate Portfolio with Senior Housing Focus - HarianBasis.co
Ventas, Inc. (NYSE:VTR) Q1 2026 Earnings Call Transcript - Insider Monkey
Ventas (VTR) Gets a Hold from Scotiabank - The Globe and Mail
Ventas, Inc. $VTR Shares Sold by UBS Group AG - MarketBeat
Scotiabank Maintains Ventas Inc(VTR.US) With Hold Rating, Maintains Target Price $93 - Moomoo
Ventas Q1 Earnings Call Highlights - MarketBeat
Ventas expects 2026 senior living investments will total $3B by year’s end - McKnight's Senior Living
Evercore ISI raises Ventas stock price target on strong SHOP results By Investing.com - Investing.com South Africa
Goldman Sachs Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $100 - Moomoo
Ventas CEO Debra Cafaro goes one-on-one with Jim Cramer - CNBC
Evercore ISI raises Ventas stock price target on strong SHOP results - Investing.com Australia
Ventas Ups 2026 Investment Guidance to $3B as Buying Remains More Attractive Than Building - Senior Housing News
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Promising Real Estate Stocks To Watch TodayApril 28th - MarketBeat
Ventas (NYSE: VTR) grows Q1 2026 revenue, expands senior housing and adds equity - Stock Titan
Ventas VTR Q1 2026 Earnings Call Transcript - The Motley Fool
Ventas Q1 2026 slides: SHOP drives 15% NOI growth, guidance raised - Investing.com India
Ventas Q1 FFO & Revenues Beat Estimates on Strong SHOP Results - Yahoo Finance
Evercore Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $94 - 富途牛牛
Welltower (WELL) Q3 2025 Earnings Transcript - AOL.com
Earnings call transcript: Ventas Q1 2026 beats expectations, stock rises By Investing.com - Investing.com India
Earnings call transcript: Ventas Q1 2026 beats expectations, stock rises - Investing.com
Ventas: Senior Housing Growth Appears Priced In (NYSE:VTR) - Seeking Alpha
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):